30th Anniversary
30th Anniversary
From failure to hope: Tracking the changing landscape of Alzheimer’s therapies
The Alzheimer's Drug Development Pipeline report, updated annually since 2016, classifies Alzheimer's therapies by their targets, their mechanisms...
30th Anniversary
Child neurology: Dr. John Bodensteiner considers the path from 1993
To celebrate our 30th year in print, Neurology Reviews invited experts to look back on 30 years of progress in their subspecialty. In this...
30th Anniversary
Thirty years of epilepsy therapy: ‘Plus ça change, plus c’est la même chose’?
To celebrate our 30th year in print, Neurology Reviews invited experts to look back on 30 years of progress in their subspecialty. In this...
30th Anniversary
Headache before the revolution: A clinician looks back
To celebrate our 30th year in print, Neurology Reviews invited experts to look back on 30 years of progress in their subspecialty. In this...
30th Anniversary
Despite ongoing challenges, experts are optimistic about the future of MS therapy
To celebrate our 30th year in print, Neurology Reviews invited experts to look back on the trajectories of various neurology subspecialties. In...
30th Anniversary
Stroke management: A 30-year retrospective
Dr. Louis Caplan looks back on the successes and failures in stroke research and treatment.